Key Takeaway From Pharma Results: How Sector Will Perform In The Near Term? | Daljeet Singh Kohli

Channel:

ET NOW

Subscribers:

1,180,000

Published on November 15, 2022 11:25:35 AM ● Video Link: https://www.youtube.com/watch?v=VCxjJ6WBGzQ

Duration: 3:58

275 views

4

Speaking to ET NOW, Daljeet Singh Kohli of Stockaxis .com, speaks about the key takeaways from the Q2 pharma results where the injectables have underperformed, some companies with speciality portfolios have outperformed and the generics are facing pricing pressure. He said that it was expected that Q2 will not be a good quarter for most of the pharma companies due to the high cost of raw materials and pricing pressure, resulting in severe pressure on margins. However, he also added that this was one of the worst quarters which is behind and a recovery will be seen in the future. Find more in this video, only on ET NOW.

#pharma #pharmasector #pharmaindustry